Connect with us

Hi, what are you looking for?

Captain Of Success
Top Stories

Stock Markets

Probe on alleged wasted meds, supplies eyed

STOCK PHOTO | Image by aleksandarlittlewolf on Freepik

A CONGRESSMAN on Thursday urged the House of Representatives to investigate the alleged P18.7 billion worth of wasted medical supplies and medicines by the Health department.

In a statement, Party-list Rep. Eduardo J. Villanueva, Jr. said he filed House Resolution (HR) No. 2127 in December last year to look into the P85 million, P7.43 billion, and P11.18 billion worth of “expired, nearly-expired, damaged, overstocked, or undistributed” medicines and medical supplies under the Health department, according to audit reports in 2021, 2022, and 2023, respectively.

“The increasing trend of unutilized medical supplies in recent years is very alarming and still haunts us. While millions of Filipinos struggle to access affordable medicines and healthcare, billions in public funds are being wasted due to inefficiencies,” he said.

“With limited fiscal space, we cannot afford to waste even a single peso,” he added. — Kenneth Christiane L. Basilio

    You May Also Like

    Stock Markets

    Students of the Institute of Civil Engineering of the University of the Philippines Diliman experience what it’s like on-board the Circular Explorer and attend...

    Stock Markets

    THE DEVELOPMENT Bank of the Philippines (DBP) will again request for regulatory relief this year as it seeks to boost its capital position. “Just...

    Stock Markets

    In the photo are (seated L to R) Francisco “Coco” D.C. Mauricio, WeFund Lending Corp. President and CEO; Danilo “Bong” J. Mojica II, UnionDigital...

    Stock Markets

    BW FILE PHOTO THE NATIONAL Government’s (NG) debt service bill surged year on year in November as both interest and amortization payments rose, data...

    Disclaimer: CaptainOfSuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.